The Apple Watch Series 9 and Ultra 2 wearables are back on sale via the manufacturer. We knew this was coming (January 19, 2024), after a federal appeals court in Washington D.C. granted a temporary pause on an import and sales ban. The ban could be reinstated on January 10, when the International Trade Commission (ITC) decides on whether to grant Apple a longer pause.

It could also come back on January 13, which is when the same agency makes a decision regarding Apple’s redesign of both smartwatches. All told, the ban lasted little more than a day and really only impacted consumers purchasing directly from Apple, as the devices were readily available from third-party retailers.

Apple told Engadget it’s “pleased the US Court of Appeals for the Federal Circuit has stayed the exclusion order while it considers our request to stay the order pending our full appeal.” At the heart of the issue is a lawsuit issued by medical technology company Masimo, which alleges that the blood oxygen sensors used in newer Apple Watch devices violate two patents. The company also accused Apple of stealing trade secrets and poaching employees.

The ITC agreed with Masimo, which led to Apple scrambling to offer a software fix. However, it was ruled that this was a hardware issue relating to the actual sensor, leading Apple back to the drawing board. It’s expected to reveal a redesigned blood oxygen sensor by January 13. The budget-friendly Apple Watch SE was never part of this discussion, as it doesn’t have a blood oxygen sensor.

Apple has long held that the ban would cause “irreparable harm” to the company. To that end, the Watch side of Apple’s business generates around $17 billion a year, according to Bloomberg. We’ll keep you updated as this case moves forward. In the meantime, snap up the well-reviewed Apple Watch Series 9 while you still can.